Naveena, T. 2017. Empagliflozin: a wonder drug in preventing diabetic nephropathy and cardiovascular effects. International Journal of Basic & Clinical Pharmacology. 5, 5 (Jan. 2017), 1704–1707. DOI:https://doi.org/10.18203/2319-2003.ijbcp20163202.